Recently, the expression of the cyclin-dependent kinase inhibitor p21Cip1/Waf1 (p21) has been linked to cisplatin resistance in testicular cancer (11) and in ovarian cancer (12). This evidence concerns the gene CDKN1A and ovarian carcinoma.